Massive cancer screening trial tests chest X-Rays for lung cancer
NCT ID NCT01696968
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This large study looks at whether regular chest X-rays and health questionnaires can help find lung cancer early and reduce deaths. Over 154,000 people aged 55-74 took part. Researchers compare lung cancer deaths between those who got screened and those who received usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that regular chest X-rays help find lung cancer early and save lives.
- What could go wrong
- This is an observational screening study, not a treatment trial. It may not prove that screening reduces deaths, and results may not apply to newer screening methods like CT scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could spot cancers that standard scans overlook
- Can a conversation aid empower lung cancer patients?
- Can couples coping together ease the burden of advanced cancer?
- Can a custom toolkit help indigenous smokers spot lung cancer earlier?
- Study tests if teaching doctors and patients boosts lung cancer screening
- Could a vaccine stop lung cancer in smokers? early trial launches